{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:08:08Z","timestamp":1777500488132,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007747","name":"University of Utah","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["U01DA039550"],"award-info":[{"award-number":["U01DA039550"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["N01DA-14-7788"],"award-info":[{"award-number":["N01DA-14-7788"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.bbrc.2017.04.117","type":"journal-article","created":{"date-parts":[[2017,4,22]],"date-time":"2017-04-22T22:47:27Z","timestamp":1492901247000},"page":"690-694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate"],"prefix":"10.1016","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1235-0759","authenticated-orcid":false,"given":"Hanna N.","family":"Wetzel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose P.","family":"Webster","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima O.","family":"Saeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6211-1414","authenticated-orcid":false,"given":"Terence L.","family":"Kirley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Ball","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew B.","family":"Norman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2017.04.117_bib1","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2217\/imt.12.19","article-title":"Predicting the clinical efficacy and potential adverse effects of a humanized anticocaine monoclonal antibody","volume":"4","author":"Norman","year":"2012","journal-title":"Immunotherapy"},{"key":"10.1016\/j.bbrc.2017.04.117_bib2","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1021\/ac030037c","article-title":"Detection and time course of cocaine N-oxide and other cocaine metabolites in human plasma by liquid chromatography\/tandem mass spectrometry","volume":"75","author":"Lin","year":"2003","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbrc.2017.04.117_bib3","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/archgenpsychiatry.2009.128","article-title":"Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial","volume":"66","author":"Martell","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.bbrc.2017.04.117_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.drugalcdep.2014.04.003","article-title":"Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial","volume":"140","author":"Kosten","year":"2014","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbrc.2017.04.117_bib5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1124\/dmd.114.057034","article-title":"A\u00a0recombinant humanized anti-cocaine monoclonal antibody inhibits the distribution of cocaine to the brain in rats","volume":"42","author":"Norman","year":"2014","journal-title":"Drug Metabolism Dispos."},{"key":"10.1016\/j.bbrc.2017.04.117_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4161\/21645515.2014.990856","article-title":"Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment","volume":"11","author":"Kirley","year":"2015","journal-title":"Hum. Vaccin Immunother."},{"key":"10.1016\/j.bbrc.2017.04.117_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.intimp.2014.10.025","article-title":"The effects of a humanized recombinant anti-cocaine monoclonal antibody on the disposition of cocaethylene in mice","volume":"23","author":"Wetzel","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bbrc.2017.04.117_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.drugalcdep.2016.09.024","article-title":"The effects of a repeated dose of a recombinant humanized anti-cocaine monoclonal antibody on cocaine self-administration in rats","volume":"168","author":"Wetzel","year":"2016","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.bbrc.2017.04.117_bib9","series-title":"Center for Biologic Evalulation and Research","article-title":"For the submission of chemistry, manufacturing, and controls information for a therapeutic recombinant dna-derived product or a monoclonal antibody product for in\u00a0vivo use","year":"1996"},{"key":"10.1016\/j.bbrc.2017.04.117_bib10","article-title":"The state-of-play and future of antibody therapeutics","author":"Elgundi","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbrc.2017.04.117_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bbrc.2016.06.099","article-title":"Structural characterization of expressed monoclonal antibodies by single sample mass spectral analysis after IdeS proteolysis","volume":"477","author":"Kirley","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2017.04.117_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ejpb.2016.01.005","article-title":"N-glycosylation heterogeneity and the influence on structure, function and pharmacokinetics of monoclonal antibodies and Fc fusion proteins","volume":"100","author":"Higel","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.bbrc.2017.04.117_bib13","first-page":"56","article-title":"Consistent production of genetically stable mammalian cell lines","volume":"25","author":"Bleck","year":"2012","journal-title":"Biopharm. Int."},{"key":"10.1016\/j.bbrc.2017.04.117_bib14","series-title":"Guide for the Care and Use of Laboratory Animals","author":"Institute for Laboratory Animal Research","year":"2011"},{"key":"10.1016\/j.bbrc.2017.04.117_bib15","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1021\/jm030351z","article-title":"Three-dimensional quantitative structure-activity relationship modeling of cocaine binding by a novel human monoclonal antibody","volume":"47","author":"Paula","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.bbrc.2017.04.117_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/jat\/25.7.497","article-title":"A\u00a0validated liquid chromatography-atmospheric pressure chemical ionization-tandem mass spectrometry method for quantitation of cocaine and benzoylecgonine in human plasma","volume":"25","author":"Lin","year":"2001","journal-title":"J.\u00a0Anal. Toxicol."},{"key":"10.1016\/j.bbrc.2017.04.117_bib17","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ejphar.2005.08.016","article-title":"Monoclonal IgG affinity and treatment time alters antagonism of (+)-methamphetamine effects in rats","volume":"521","author":"Byrnes-Blake","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2017.04.117_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1097\/00007691-200006000-00006","article-title":"Mechanisms of cocaine hydrolysis and metabolism in\u00a0vitro and in\u00a0vivo: a clarification","volume":"22","author":"Warner","year":"2000","journal-title":"Ther. Drug Monit."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17307994?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X17307994?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T15:14:42Z","timestamp":1777389282000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X17307994"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0006291X17307994"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.117","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of a recombinant humanized anti-cocaine monoclonal antibody produced from multiple clones for the selection of a master cell bank candidate","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2017.04.117","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}